Correlation Between IBio, Common and AEZS Old
Can any of the company-specific risk be diversified away by investing in both IBio, Common and AEZS Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IBio, Common and AEZS Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iBio, Common Stock and AEZS Old, you can compare the effects of market volatilities on IBio, Common and AEZS Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IBio, Common with a short position of AEZS Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of IBio, Common and AEZS Old.
Diversification Opportunities for IBio, Common and AEZS Old
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between IBio, and AEZS is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding iBio, Common Stock and AEZS Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AEZS Old and IBio, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iBio, Common Stock are associated (or correlated) with AEZS Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AEZS Old has no effect on the direction of IBio, Common i.e., IBio, Common and AEZS Old go up and down completely randomly.
Pair Corralation between IBio, Common and AEZS Old
If you would invest 242.00 in iBio, Common Stock on December 17, 2024 and sell it today you would earn a total of 266.00 from holding iBio, Common Stock or generate 109.92% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
iBio, Common Stock vs. AEZS Old
Performance |
Timeline |
iBio, Common Stock |
AEZS Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
IBio, Common and AEZS Old Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with IBio, Common and AEZS Old
The main advantage of trading using opposite IBio, Common and AEZS Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IBio, Common position performs unexpectedly, AEZS Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AEZS Old will offset losses from the drop in AEZS Old's long position.IBio, Common vs. Jaguar Animal Health | IBio, Common vs. GeoVax Labs | IBio, Common vs. Ocugen Inc | IBio, Common vs. Tonix Pharmaceuticals Holding |
AEZS Old vs. Pulmatrix | AEZS Old vs. Bio Path Holdings | AEZS Old vs. Moleculin Biotech | AEZS Old vs. Adial Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Valuation Check real value of public entities based on technical and fundamental data |